Potential compensatory responses through autophagic/lysosomal pathways in neurodegenerative diseases

Autophagy

Volumn 2, Issue 3, 2006, Pages 234-237

  Butler, David ^a   Nixon, Ralph A ^b,c   Bahr, Ben A ^a  

^a UNIVERSITY OF CONNECTICUT   (United States)

^b NATHAN S KLINE INSTITUTE FOR PSYCHIATRIC RESEARCH   (United States)

^c NEW YORK UNIVERSITY   (United States)

Author keywords

Alzheimer's disease; Autophagy; Lysosomal activation; Lysosomal modulation; PADK; Protein accumulation pathology; Protein clearance; Synaptic pathology

Indexed keywords

CELL PROTEIN;

AUTOPHAGY; CELL DEATH; CELL PROTECTION; CELL VACUOLE; DEGENERATIVE DISEASE; HUMAN; LYSOSOME; NERVE CELL DEGENERATION; NEUROPATHY; OLIGOMERIZATION; PROTEIN DEGRADATION; PROTEIN LOCALIZATION; PROTEIN SYNTHESIS; REVIEW;

EID: 33745862719     PISSN: 15548627     EISSN: 15548635     Source Type: Journal    
DOI: 10.4161/auto.2729     Document Type: Review

References (32)

1. Coleman P, Federoff H, Kurlan R. A focus on the synapse for neuroprotection in Alzheimer disease and other dementias. Neurology 2004; 63:1155-62.
2. Bahr BA, Bendiske J. The neuropathogenic contributions of lysosomal dysfunction. J Neurochem 2002; 83:481-9.
3. Bendiske J, Caba E, Brown QB, Bahr BA. Intracellular deposition, microtubule destabilization, and transport failure: An 'early' pathogenic cascade leading to synaptic decline. J Neuropathol Exp Neurol 2002; 61:640-50.
4. Bendiske J, Bahr BA. Lysosomal activation is a compensatory response against protein accumulation and associated synaptopathogenesis - An approach for slowing Alzheimer's disease? J Neuropathol Exp Neurol 2003; 62:451-63.
5. Butler D, Brown QB, Chin DJ, Batey L, Karim S, Mutneja MS, Karanian DA, Bahr BA. Cellular responses to protein accumulation involve autophagy and lysosomal enzyme activation. Rejuvenation Res 2005; 8:227-37.
6. Callahan LM, Vaules WA, Coleman PD. Quantitative decrease in synaptophysin message expression and increase in cathepsin D message expression in Alzheimer disease neurons containing neurofibrillary tangles. J Neuropathol Exp Neurol 1999; 58:275-87.
7. Mucke L, Masliah E, Yu GO, Mallory M, Rockenstein EM, Tatsuno G, Hu K, Kholodenko D, Johnson-Wood K, McConlogue L. High level neuronal expression of Aβ 1-42 in wild-type human amyloid protein precursor transgenic mice: Synaptotoxicity without plaque formation. J Neurosci 2000; 20:4050-8.
8. Stokin GB, Lillo C, Falzone TL, Brusch RG, Rockenstein E, Mount SL, Raman R, Davies P, Masliah E, Williams DS, Goldstein LS. Axonopathy and transport deficits early in the pathogenesis of Alzheimer's disease. Science 2005; 307:1282-8.
9. Cataldo AM, Barnert JL, Berman SA, Berman SA, Li J, Quatless S, Bursztajn S. Gene expression and cellular content of cathepsin D in Alzheimer's disease brain: Evidence for early upregulation of the endosomal-lysosomal system. Neuron 1995; 14:671-80.
10. Qin ZH, Wang Y, Kegel KB, Kazantsev A, Apostol BL, Thompson LM, Yoder J, Aronin N, DiFiglia M. Autophagy regulates the processing of amino terminal huntingtin fragments. Hum Mol Genet 2003; 12:3231-44.
11. Meredith GE, Totterdel S, Petroske E, Santa Cruz K, Callison RC, Lau YS. Lysosomal malfunction accompanies α-synuclein aggregation in a progressive mouse model of Parkinson's disease. Brain Res 2002; 956:156-65.
12. Nixon RA, Wegiel J, Kumar A, Yu WH, Peterhoff C, Cataldo A, Cuervo AM. Extensive involvement of autophagy in Alzheimer disease: An immuno-electron microscopy study. J Neuropathol Exp Neurol 2005; 64:113-22.
13. Rubinsztein DC, DiFiglia M, Heintz N, Nixon RA, Qin ZH, Ravikumar B, Stefanis L, Tolkovsky A. Autophagy and its possible roles in nervous system diseases, damage and repair. Autophagy 2005; 1:11-22.
14. Butler D, Bahr BA. Oxidative stress and lysosomes: CNS-related consequences and implications for lysosomal enhancement strategies and induction of autophagy. Antioxid Redox Signal 2006; 8:185-96.
15. Collins PR, Stack CM, O'Neill SM, Doyle S, Ryan T, Brennan GP, Mousley A, Stewart M, Maule AG, Dalton JP, Donnelly S. Cathepsin LI, the major protease involved in liver fluke (Fasciola hepatica) virulence: Propeptide cleavage sites and autoactivation of the zymogen secreted from gastrodermal cells. J Biol Chem 2004; 279:17038-46.
16. Nixon RA. Autophagy: Friend, foe, or turncoat? Trends Neurosci 2006; In press.
17. Cuervo AM, Stefanis L, Fredenburg R, Lansbury PT, Sulzer D. Impaired degradation of mutant α-synuclein by chaperone-mediated autophagy. Science 2004; 305:1292-5.
18. Stroikin Y, Dalen H, Loof S, Terman A. Inhibition of autophagy with 3-methyladenine results in impaired turnover of lysosomes and accumulation of lipofuscin-like material. Eur J Cell Biol 2004; 83:583-90.
19. Yu WH, Cuervo AM, Kumar A, Peterhoff CM, Schmidt SD, Lee JH, Mohan PS, Mercken M, Farmery MR, Tjernberg LO, Jiang Y, Duff K, Uchiyama Y, Naslund J, Mathews PM, Cataldo AM, Nixon RA. Macroautophagy-A novel β-amyloid peptide-generating pathway activated in Alzheimer's disease. J Cell Biol 2005; 171:87-98.
20. Takahashi RH, Milner TA, Li F, Nam EE, Edgar MA, Yamaguchi H, Beal MF, Xu HX, Grecngard P, Goutas GK. Intraneuronal Alzheimer Aβ 42 accumulates in multivesicular bodies and is associated with synaptic pathology. Am J Pathol 2002; 161:1869-79.
21. Takahashi RH, Almeida GC, Kearney PF, Yu F, Lin MT, Milner TA, Goutas GK. Oligomerization of Alzheimer's β-amyloid within processes and synapses of cultured neurons and brain. J Neurosci 2004; 24:3592-9.
22. Sikorska B, Liberski PP, Giraud P, Kopp N, Brown P. Autophagy is a part of ultrastructural synaptic pathology in Creutzfeldt-Jakob disease: A brain biopsy study. Int J Biochem Cell Biol 2004; 36:2563-73.
23. Kayed R, Head E, Thompson JL, McIntire TM, Milton SC, Cotman CW, Glabe CG. Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis. Science 2003; 300:486-9.
24. Ravikumar B, Vacher C, Berger Z, Davies JE, Luo S, Oroz LG, Scaravilli F, Easton DF, Duden R, O'Kane CJ, Rubinsztein DC. Inhibition of mTOR induces autophagy and reduces toxicity of polyglutamine expansions in fly and mouse models of Huntington disease. Nature Genet 2004; 36:585-95.
25. Yamamoto A, Cremona ML, Rothman JE. Autophagy-mediated clearance of huntingtin aggregates triggered by the insulin-signaling pathway. J Cell Biol 2006; 172:719-31.
26. Bjorkoy G, Lamark T, Brech A, Outzen H, Perander M, Overvatn A, Stenmark H, Johansen T. p62/SQSTM1 forms protein aggregates degraded by autophagy and has a protective effect on huntingtin-induced cell death. J Cell Biol 2005; 171:603-14.
27. Lee HJ, Khoshaghideh F, Patel S, Lee SJ. Clearance of α-synuclein oligomeric intermediates via the lysosomal degradation pathway. J Neurosci 2004; 24:1888-96.
28. A receptors in Caenorhabditis elegans. J Neurosci 2006; 26:711-20.
29. Grady CL, McIntosh AR, Beig S, Keightley ML, Burian H, Black SE. Evidence from functional neuroimaging of a compensatory prefrontal network in Alzheimer's disease. J Neurosci 2003; 23:986-93.
30. Head E, Lott IT, Hof PR, Bouras C, Su JH, Kim R, Haier R, Cotman CW. Parallel compensatory and pathological events associated with tau pathology in middle aged individuals with Down syndrome. J Neuropathol Exp Neurol 2003; 62:917-26.
31. Szot P, White SS, Greenup JL, Leverenz JB, Peskind ER, Raskind MA. Compensatory changes in the noradrenergic nervous system in the locus ceruleus and hippocampus of postmortem subjects with Alzheimer's disease and dementia with Lewy bodies. J Neurosci 2006; 26:467-78.
32. Nixon RA, Mathews PM, Cataldo AM, Mohan PS, Schmidt SD, Duff K, Berg M, Marks N, Peteroff C, Sershen H. In vivo perturbation of lysosomal function promotes neurodegeneration in the PS1 M146V/APP K670N,M671L mouse model of Alzheimer's disease pathology. In: Iqbal K, Sisodia SS, Winblad B, eds. Alzheimer's Disease: Advances in Etiology, Pathogenesis and Therapeutics. New York: John Wiley and Sons, 2001:687-96.